CXCL9/CXCL10/CXCL11 gene therapy(Omega Therapeutics)

N/A

Report date: 2024/09/09 16:52:31

Base Information

Drug NameCXCL9/CXCL10/CXCL11 gene therapy(Omega Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionC-X-C motif chemokine ligand 10 modulatorsC-X-C motif chemokine 9 modulatorsC-X-C Motif Chemokine Ligand 11 modulators
TargetsC-X-C motif chemokine ligand 10C-X-C motif chemokine 9C-X-C Motif Chemokine Ligand 11
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmega Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOmega Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A